drugset

drugset / Trial / NCT00257569

Study Of Atopic Dermatitis In Pediatrics

NCT00257569 ↗

Phase 3 Completed 278 enrolled GlaxoSmithKline

RandomizedParallel-groupDouble-blindTreatment

Summary

To verify of cetirizine dry syrup to ketotifen dry syrup in the change in the severity of pruritus of the treatment period.

Timeline

Start: 2005-08
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cetirizine	Other / unclassified	—	—

Indications